Baidu
map

Anesthesiology:局麻不增加膝关节置换后跌倒风险

2014-05-08 佚名 International Medica

《麻醉学》(Anesthesiology)杂志上的, 一项研究显示两类局部麻醉不会使那些接受膝关节置换术患者在最初几天内的跌倒风险增加。 研究分析了将近20万膝关节置换术中的麻醉类型,其中76%使用普通麻醉,11%使用脊柱或硬膜外麻醉,13%使用轴索和普通麻醉联合。此外,还有12%的患者接受外周神经阻滞(PNB)。 研究者还分析了那些在医院跌倒患者的麻醉类型,在接受普通麻醉的患者中,1.6%跌

《麻醉学》(Anesthesiology)杂志上的, 一项研究显示两类局部麻醉不会使那些接受膝关节置换术患者在最初几天内的跌倒风险增加。

研究分析了将近20万膝关节置换术中的麻醉类型,其中76%使用普通麻醉,11%使用脊柱或硬膜外麻醉,13%使用轴索和普通麻醉联合。此外,还有12%的患者接受外周神经阻滞(PNB)。

研究者还分析了那些在医院跌倒患者的麻醉类型,在接受普通麻醉的患者中,1.6%跌倒,而轴索麻醉的有1.3%跌倒,联合普通和轴索麻醉的有1.5%跌倒。还接受PNB的患者跌倒率为1.6%。

当患者在康复过程中跌倒,他们的预后很可能较差,手术后30天出现心脏、肺部疾病的可能性更高,死亡率也较高。

研究表明,麻醉类型不会增加跌倒风险,脊柱或硬膜外麻醉与普通麻醉相比甚至可以降低跌倒风险。








版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2050404, encodeId=03df20504040f, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Tue Feb 17 14:18:00 CST 2015, time=2015-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1742282, encodeId=7e441e422821f, content=<a href='/topic/show?id=39cae96626f' target=_blank style='color:#2F92EE;'>#置换#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79662, encryptionId=39cae96626f, topicName=置换)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a7c35056336, createdName=yxch48, createdTime=Mon Mar 16 02:18:00 CST 2015, time=2015-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1663845, encodeId=f3941663845ba, content=<a href='/topic/show?id=f6304e66252' target=_blank style='color:#2F92EE;'>#局麻#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47662, encryptionId=f6304e66252, topicName=局麻)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48cb25693766, createdName=12498b08m98暂无昵称, createdTime=Sun Mar 22 08:18:00 CST 2015, time=2015-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1588158, encodeId=d3e3158815869, content=<a href='/topic/show?id=1cb8e014e0' target=_blank style='color:#2F92EE;'>#ESI#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7014, encryptionId=1cb8e014e0, topicName=ESI)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4f817593223, createdName=skhzy, createdTime=Sat May 10 01:18:00 CST 2014, time=2014-05-10, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2050404, encodeId=03df20504040f, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Tue Feb 17 14:18:00 CST 2015, time=2015-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1742282, encodeId=7e441e422821f, content=<a href='/topic/show?id=39cae96626f' target=_blank style='color:#2F92EE;'>#置换#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79662, encryptionId=39cae96626f, topicName=置换)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a7c35056336, createdName=yxch48, createdTime=Mon Mar 16 02:18:00 CST 2015, time=2015-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1663845, encodeId=f3941663845ba, content=<a href='/topic/show?id=f6304e66252' target=_blank style='color:#2F92EE;'>#局麻#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47662, encryptionId=f6304e66252, topicName=局麻)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48cb25693766, createdName=12498b08m98暂无昵称, createdTime=Sun Mar 22 08:18:00 CST 2015, time=2015-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1588158, encodeId=d3e3158815869, content=<a href='/topic/show?id=1cb8e014e0' target=_blank style='color:#2F92EE;'>#ESI#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7014, encryptionId=1cb8e014e0, topicName=ESI)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4f817593223, createdName=skhzy, createdTime=Sat May 10 01:18:00 CST 2014, time=2014-05-10, status=1, ipAttribution=)]
    2015-03-16 yxch48
  3. [GetPortalCommentsPageByObjectIdResponse(id=2050404, encodeId=03df20504040f, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Tue Feb 17 14:18:00 CST 2015, time=2015-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1742282, encodeId=7e441e422821f, content=<a href='/topic/show?id=39cae96626f' target=_blank style='color:#2F92EE;'>#置换#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79662, encryptionId=39cae96626f, topicName=置换)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a7c35056336, createdName=yxch48, createdTime=Mon Mar 16 02:18:00 CST 2015, time=2015-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1663845, encodeId=f3941663845ba, content=<a href='/topic/show?id=f6304e66252' target=_blank style='color:#2F92EE;'>#局麻#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47662, encryptionId=f6304e66252, topicName=局麻)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48cb25693766, createdName=12498b08m98暂无昵称, createdTime=Sun Mar 22 08:18:00 CST 2015, time=2015-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1588158, encodeId=d3e3158815869, content=<a href='/topic/show?id=1cb8e014e0' target=_blank style='color:#2F92EE;'>#ESI#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7014, encryptionId=1cb8e014e0, topicName=ESI)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4f817593223, createdName=skhzy, createdTime=Sat May 10 01:18:00 CST 2014, time=2014-05-10, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2050404, encodeId=03df20504040f, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Tue Feb 17 14:18:00 CST 2015, time=2015-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1742282, encodeId=7e441e422821f, content=<a href='/topic/show?id=39cae96626f' target=_blank style='color:#2F92EE;'>#置换#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79662, encryptionId=39cae96626f, topicName=置换)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a7c35056336, createdName=yxch48, createdTime=Mon Mar 16 02:18:00 CST 2015, time=2015-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1663845, encodeId=f3941663845ba, content=<a href='/topic/show?id=f6304e66252' target=_blank style='color:#2F92EE;'>#局麻#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47662, encryptionId=f6304e66252, topicName=局麻)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48cb25693766, createdName=12498b08m98暂无昵称, createdTime=Sun Mar 22 08:18:00 CST 2015, time=2015-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1588158, encodeId=d3e3158815869, content=<a href='/topic/show?id=1cb8e014e0' target=_blank style='color:#2F92EE;'>#ESI#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7014, encryptionId=1cb8e014e0, topicName=ESI)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4f817593223, createdName=skhzy, createdTime=Sat May 10 01:18:00 CST 2014, time=2014-05-10, status=1, ipAttribution=)]
    2014-05-10 skhzy

相关资讯

JBJS:脊髓麻醉与全麻实施初次全膝关节置换的短期并发症差异

以往多项研究表明 [1-7],相比全麻,脊髓麻醉实施骨关节手术的术后深静脉血栓形成发生率更低,手术时间更短,手术失血量更少。最近,美国爱荷华大学医院及临床研究中心的Andrew J. Pugely, MD等实施了一项临床观察研究,对全膝关节置换患者应用全麻和脊髓麻醉的围手术期(30天内)并发症发生率及死亡率进行对比评价,他们的研究结果发表在最新一期的JBJS(Am)上,该研究的证据级别为治疗性研究

国内首例同种异体复合组织移植伸膝装置修复术

3月3日,由第四军医大学唐都医院骨科实施修复伸膝装置破坏手术的患者来院复查,经过术后1年多随访,患者完全恢复正常行走。根据文献检索,这是国内首例同种异体复合组织移植术治疗膝关节置换后伸膝装置破坏的病例。77岁的王大爷因患膝关节骨性关节炎,11年在某医院接受了膝关节置换手术,术后仅半年发生骨折,髌骨假体脱落,无法行走,严重困扰患者日常生活,辗转国内多家医院均没有良好的治疗方案,最终慕名来到唐都医院骨

定制式膝关节置换系统制造商ConforMIS获得1.677亿美元风险投资

2013年8月2日骨科种植体厂家ConforMIS披露,其E轮融资已达到惊人的1.677亿美元,涵盖了美国、欧洲、亚洲和中东地区的顶级主权财富基金和私募股权基金。 ConforMIS将利用这笔资金将2代iTOTAL全膝关节置换系统商品化,同时寻求新的并购机会。 ConforMIS公司成立于2004年,是一家定制式膝关节置换系统制造商。iTOTAL全膝关节置换系统搭配iFI

Baidu
map
Baidu
map
Baidu
map